NAS:HSDT (USA)
Â
Class A
$
5.15
+0.035 (+0.68%)
03:57 PM EST
Business Description
Helius Medical Technologies Inc
NAICS : 325413
SIC : 3842
ISIN : US42328V5049
Share Class Description:
HSDT: Class ADescription
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 90.91 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -31.45 | |||||
| Beneish M-Score | -1.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -66.2 | |||||
| 3-Year EBITDA Growth Rate | 67.5 | |||||
| 3-Year EPS without NRI Growth Rate | 68 | |||||
| 3-Year FCF Growth Rate | 67.3 | |||||
| 3-Year Book Growth Rate | -70.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.97 | |||||
| 9-Day RSI | 30.73 | |||||
| 14-Day RSI | 36.78 | |||||
| 6-1 Month Momentum % | -18.85 | |||||
| 12-1 Month Momentum % | -44.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.96 | |||||
| Quick Ratio | 3.72 | |||||
| Cash Ratio | 2.76 | |||||
| Days Inventory | 343.96 | |||||
| Days Sales Outstanding | 49.54 | |||||
| Days Payable | 384.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -188.7 | |||||
| Shareholder Yield % | 1.16 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 9.47 | |||||
| Operating Margin % | -1905.12 | |||||
| Net Margin % | -1374.22 | |||||
| FCF Margin % | -1621.89 | |||||
| ROE % | -183.15 | |||||
| ROA % | -75.85 | |||||
| ROIC % | -974.81 | |||||
| ROC (Joel Greenblatt) % | -2970.7 | |||||
| ROCE % | -123.37 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.97 | |||||
| PB Ratio | 1.56 | |||||
| Price-to-Tangible-Book | 1.58 | |||||
| EV-to-EBIT | 0.05 | |||||
| EV-to-EBITDA | 0.05 | |||||
| EV-to-Revenue | -0.98 | |||||
| EV-to-Forward-Revenue | 0.03 | |||||
| EV-to-FCF | 0.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.76 | |||||
| Earnings Yield (Greenblatt) % | 2000 | |||||
| FCF Yield % | -228.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSDT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Helius Medical Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.644 | ||
| EPS (TTM) ($) | -13.95 | ||
| Beta | 1.08 | ||
| Volatility % | 92.19 | ||
| 14-Day RSI | 36.78 | ||
| 14-Day ATR ($) | 0.425952 | ||
| 20-Day SMA ($) | 5.79608 | ||
| 12-1 Month Momentum % | -44.93 | ||
| 52-Week Range ($) | 4.29 - 14.44 | ||
| Shares Outstanding (Mil) | 0.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Helius Medical Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Helius Medical Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Helius Medical Technologies Inc Frequently Asked Questions
What is Helius Medical Technologies Inc(HSDT)'s stock price today?
The current price of HSDT is $5.15. The 52 week high of HSDT is $14.44 and 52 week low is $4.29.
When is next earnings date of Helius Medical Technologies Inc(HSDT)?
The next earnings date of Helius Medical Technologies Inc(HSDT) is 2024-05-10 Est..
Does Helius Medical Technologies Inc(HSDT) pay dividends? If so, how much?
Helius Medical Technologies Inc(HSDT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers